Butterfly Network, Inc. (NYSE:BFLY) is among the Best Brain-Computer Interface Stocks.
On June 18, Butterfly Network, Inc. (NYSE:BFLY) commented on Midjourney's launch of a full-body imaging system, outlining its role in the scanner's underlying hardware and future scaling plans. The company said the current prototype integrates 40 Ultrasound-on-Chip imaging modules per system under an existing co-development agreement. The future versions are expected to use significantly more modules as the platform grows.
CEO Joseph DeVivo called the system "an extraordinary whole-body scanner," stating it works without radiation or magnetic risk and uses "about half a million sensors" and more than two petaflops of processing power. He added that the device is designed for frequent use, allowing continuous monitoring of physiological changes.
DeVivo said Butterfly Network, Inc. (NYSE:BFLY) supports Midjourney's effort to expand access to imaging data, calling the roadmap introduced by founder David Holz a potential commercial opportunity. The company also noted its prior agreement outlines up to $74 million in expected payments over five years.
Butterfly Network, Inc. (NYSE:BFLY) develops a medical imaging device that lowers the cost of real-time, three-dimensional imaging and treatment. It develops and markets the iQ Device, a whole-body portable ultrasound scanner, as well as related hosted, web-based applications, application programming interfaces, and platform services to physicians and other licensed health care providers.
